Amvis Holdings, Inc.
Purpose and Overview of This Transaction
Sale of 47 Ishinkan facilities in western Japan to NSSK for receipt of 17.4 billion yen. Strengthening of the financial base after the transfer will expand capacity to invest in growth areas. Maintain Ishinkan as a stable earnings base and shift the comprehensive medical support business into a growth driver. Upon approval at an extraordinary shareholders meeting, transfer gains are expected in the fiscal year ending September 2027.
Key Figures
- Transfer target: 47 Ishinkan facilities mainly in western Japan
- Transfer price: 17.4 hundred million yen
- Transfer date: November 16
- Expected increase in cash: 17.0 hundred million yen
AI要約
Overview and Strategy of the Proposal
By transferring 47 Ishinkan facilities primarily in western Japan, the company will strengthen its financial base and position the comprehensive medical support business as a new growth driver. The transfer proceeds and reduction in interest-bearing debt will improve net debt, allowing concentration of resources in the Tokyo metropolitan area and eastern Japan while maintaining the Ishinkan business as a stable revenue base.
Future Growth and Organizational Structure
Secure investment capacity to expand the comprehensive medical support business and cultivate AIZIA (a new business) as the core for DX/AI introduction and expanded deployment. Establish a structure to delegate authority for Ishinkan to the next generation, accelerating allocation of management resources and business expansion.
Amvis Holdings, Inc.
Company overview · Stock price · Financial data · All IR
